Table 1.
Sensitivity Analysis Results: Ten-Year Biosimilar Cost Savings
| Biosimilar Price Relative to Reference Biologic | Biosimilar Market Share Assumption | ||||||
|---|---|---|---|---|---|---|---|
| 20% | 25% | 30% | 35% | 40% | 45% | 50% | |
| 50% | $60 | $75 | $90 | $105 | $120 | $135 | $150 |
| 55% | $54 | $67 | $81 | $94 | $108 | $121 | $135 |
| 60% | $48 | $60 | $72 | $84 | $96 | $108 | $120 |
| 65% | $42 | $52 | $63 | $73 | $84 | $94 | $105 |
| 70% | $36 | $45 | $54 | $63 | $72 | $81 | $90 |
| 75% | $30 | 37 | $45 | $52 | $60 | $67 | $75 |
| 80% | $24 | $30 | $36 | $42 | $48 | $54 | $60 |
SOURCE: RAND authors' calculations.
NOTE: All dollar amounts are in billions.